Top compounds associated with response to CRYGC

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.047	0.2
mRNA	tanespimycin:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.052	0.2
mRNA	SL 0101-1	GDSC1000	pan-cancer	AAC	-0.049	0.2
mRNA	Erlotinib	FIMM	pan-cancer	AAC	0.24	0.2
mRNA	Sorafenib	CCLE	pan-cancer	AAC	-0.064	0.2
mRNA	fingolimod	CTRPv2	pan-cancer	AAC	0.049	0.2
mRNA	hyperforin	CTRPv2	pan-cancer	AAC	0.054	0.2
mRNA	tivantinib	CTRPv2	pan-cancer	AAC	0.062	0.2
mRNA	tacedinaline	CTRPv2	pan-cancer	AAC	0.053	0.2
mRNA	JW-7-52-1	GDSC1000	pan-cancer	AAC	0.071	0.2

Download CSV